Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma.
Perez-de-Llano L, Scelo G, Canonica GW, Chen W, Henley W, Larenas-Linnemann D, Peters MJ, Pfeffer PE, Tran TN, Ulrik CS, Popov TA, Sadatsafavi M, Hew M, Máspero J, Gibson PG, Christoff GC, Fitzgerald JM, Torres-Duque CA, Porsbjerg CM, Papadopoulos NG, Papaioannou AI, Heffler E, Iwanaga T, Al-Ahmad M, Kuna P, Fonseca JA, Al-Lehebi R, Rhee CK, Koh MS, Cosio BG, Perng Steve DW, Mahboub B, Menzies-Gow AN, Jackson DJ, Busby J, Heaney LG, Patel PH, Wang E, Wechsler ME, Altraja A, Lehtimäki L, Bourdin A, Bjermer L, Bulathsinhala L, Carter V, Murray R, Beastall A, Denton E, Price DB.
Perez-de-Llano L, et al. Among authors: heaney lg.
Ann Allergy Asthma Immunol. 2024 May;132(5):610-622.e7. doi: 10.1016/j.anai.2023.12.023. Epub 2023 Dec 25.
Ann Allergy Asthma Immunol. 2024.
PMID: 38151100
Free article.